BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 744897)

  • 1. [Studies on renal prostaglandin E in essential hypertension: relationships among urinary prostaglandin E, sodium balance, renin-angiotensin-aldosterone system and renal kallikrein-kinin system (author's transl)].
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Seino M; Sakurai Y; Saito K; Kusaka T; Imai Y; Ito T; Ritsu K; Haruyama T; Otsuka Y; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1978 Dec; 67(12):1537-45. PubMed ID: 744897
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension.
    Abe K; Yasujima M; Sakurai Y; Chiba S; Itoh T; Imai Y; Sato M; Haruyama T; Omata K; Goto T; Sato K; Hiwatari M; Otsuka Y; Yoshinaga K
    Jpn Circ J; 1979 Dec; 43(12):1105-16. PubMed ID: 396385
    [No Abstract]   [Full Text] [Related]  

  • 4. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.
    Abe K; Sato M; Kasai Y; Haruyama T; Sato K; Miyazaki S; Imai Y; Hiwatari M; Itoh T; Sakurai Y; Goto T; Tajima J; Seino M; Yoshinaga K
    Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on kallikrein-kinin system in essential hypertension: urinary kallikrein-kinin system and renin-angiotensin-aldosterone system (author's transl)].
    Abe K; Irokawa N; Seino M; Sakurai Y; Yasujima M; Chiba S; Ito T; Saito K; Miyazaki S; Imai Y; Kusaka T; Ritz K; Sato M; Haruyama T; Otsuka Y; Yoshinaga K; Saito T
    Nihon Naika Gakkai Zasshi; 1978 May; 67(5):483-94. PubMed ID: 670775
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bartter's syndrome: urinary prostaglandin E-like material and kallikrein; indomethacin effects.
    Halushka PV; Wohltmann H; Privitera PJ; Hurwitz G; Margolius HS
    Ann Intern Med; 1977 Sep; 87(3):281-6. PubMed ID: 900671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
    Handa M; Kondo K; Suzuki H; Saruta T
    Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intrarenal vasoactive substances in the pathogenesis of essential hypertension.
    Abe K; Yasujima M; Irokawa N; Seino M; Chiba S; Sakurai Y; Sato M; Imai Y; Saito K; Ito T; Haruyama T; Otsuka Y; Yoshinaga K
    Clin Sci Mol Med Suppl; 1978 Dec; 4():363s-366s. PubMed ID: 282087
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of alacepril on renin-angiotensin-aldosterone system and kallikrein-kinin-prostaglandin system in experimental animals.
    Hosoki K; Takeyama K; Minato H; Fukuya F; Kawahara S; Kadokawa T
    Arzneimittelforschung; 1986; 36(1):77-83. PubMed ID: 3006712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal kallikrein-kinin: its relation to renal prostaglandins and renin-angiotensin-aldosterone in man.
    Abe K; Sato M; Imai Y; Haruyama T; Sato K; Hiwatari M; Kasai Y; Yoshinaga K
    Kidney Int; 1981 Jun; 19(6):869-80. PubMed ID: 7021957
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urinary prostaglandin E in patients with hypertension--relationship to renin-angiotensin-aldosterone system (author's transl)].
    Chiba S; Abe K; Yasujima M; Sato M; Ito T; Sakurai Y; Haruyama T; Irokawa N; Otsuka Y; Yoshinaga K
    Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):739-51. PubMed ID: 7009938
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
    Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
    Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
    Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
    Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of renal prostaglandin E in urinary sodium excretion.
    Yasujima M; Abe K; Chiba S; Sato M; Irokawa N; Seino M; Imai Y; Saito K; Sakurai Y; Ito T; Haruyama T; Ritsu K; Yoshinaga K
    Jpn Circ J; 1978 May; 42(5):565-9. PubMed ID: 702774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prostaglandin and kallikrein-kinin system in essential hypertension].
    Abe K
    Nihon Rinsho; 1979 Oct; 37(10):3398-404. PubMed ID: 392129
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies of urinary kallikrein in patients with various types of hypertension (relationship to renin-angiotension-aldosterone system (author's transl)].
    Seino M
    Nihon Jinzo Gakkai Shi; 1978 Aug; 20(8):877-87. PubMed ID: 713164
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal kallikrein excretion in alcoholic cirrhosis. Relationship to other vasoactive systems.
    Zipser RD; Kerlin P; Hoefs JC; Zia P; Barg A
    Am J Gastroenterol; 1981 Mar; 75(3):183-7. PubMed ID: 7015845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bartter's syndrome: effect of indomethacin on prostaglandins, urinary kallikrein, renin-angiotensin-aldosterone system, and the response to angiotensin II antagonist.
    Sasaki H; Kawasaki T; Okumura M; Asano T; Abe K; Arakawa K
    Endocrinol Jpn; 1980 Aug; 27(4):417-29. PubMed ID: 7007031
    [No Abstract]   [Full Text] [Related]  

  • 20. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
    Oliver JA; Vinci JM; Bowden RE; Weinberger AB; Baer L; Keiser HR; Cannon PJ
    Nephron; 1981; 29(3-4):110-6. PubMed ID: 7035981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.